Gene Therapy Developer Tocagen Files for $86M IPO – Genetic Engineering & Biotechnology News (press release)
FierceBiotech |
Gene Therapy Developer Tocagen Files for $86M IPO
Genetic Engineering & Biotechnology News (press release) Tocagen, a gene therapy developer focused on treating brain cancer, will seek to raise $86 million through an initial public offering, according to an S-1 registration statement filed with the U.S. Securities and Exchange Commission. Tocagen's lead … Tocagen seeks $86M IPO to fund cancer gene therapy trial Tocagen readies IPO |
